Researchers Turn from Drugs to Mini Organs for Diabetes Cure, According to Yasmin Malhotra
Yasmin Malhotra, who has studied the pharmaceutical industry extensively, explains how a “mini organ,” not drugs, may hold the cure for Type 1 diabetes.
New York, New York (PRWEB) March 11, 2013
Yasmin Malhotra, a writer who has studied the pharmaceutical industry in great detail, is ecstatic to share the news that Diabetes Research Institute, or DRI, may have a cure for Type 1 diabetes in its sights. According to an article published by the Huffington Post, DRI, which is part of the University of Miami, has designed the DRI BioHub. This medical device, which was coined a “mini organ,” may allow researchers to cure Type 1 diabetes in just five to seven years, according to the article.
Dr. Camillo Ricordi, who is the scientific director and chief academic officer of DRI, asserts: “It [the DRI BioHub] will mimic the insulin function of a normal pancreas. It will restore natural insulin production for any patient, no matter how long they’ve had diabetes.”
While many members of the general public may have assumed that the cure for diabetes would come in the form of a pharmaceutical drug, the researchers at DRI have pinpointed an alternative method to addressing this condition. The article explains: “The BioHub is an engineered ‘mini organ’ that will house insulin-producing (islet) cells that, like normally functioning islet cells, sense blood sugar and release the precise amount of insulin to maintain normal blood sugar levels.”
If the device is successfully, it means that individuals who suffer from Type 1 diabetes (and, the article asserts, possibly other forms of the disease) can cure the condition with the use of the BioHub. According to the article, the reason why this breakthrough has finally taken place is due to the technological advances that have provided the tools researchers needed to make it happen.
Dr. Ricordi explains: “For the first time we have the convergence of all the different technologies we’ve been developing over the years, and that we need, those dealing with autoimmunity, cell sources and auto immune suppression, to have a biologic cure.”
Yasmin Malhotra encourages researchers to continue on this path in an effort to create a cure that will be applicable to millions of diabetes patients. “Diabetes is a difficult disease to live with, and it can be fatal if not managed correctly,” Malhotra states. “But simply managing this condition can be a full-time job for many people. If the BioHub is successful, individuals who suffer from diabetes will be able to finally reclaim their lives.”
[Yasmin Malhotra is a writer who has penned multiple articles on varying topics, including the pharmaceutical industry, globalization, immigration, AIDS, art, and more. A travel enthusiast, Yasmin Malhotra is keen to learn more about new cultures and is particularly fond of surfing. Additionally, Yasmin Malhotra is focused on her efforts in the social work field and is active in the endeavors of many non-profit organizations that support various causes, from senior care to education to providing financial assistance to individuals in need.
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2013/3/prweb10512493.htm